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ORIGINAL ARTICLE
Abstract
Introduction: The management of thoracic aortic disease involving 
the ascending aorta, aortic arch and descending thoracic aorta are techni-
cally challenging and is an area in constant development and innovation. 
Objective: To analyze early and midterm results of hybrid treatment 
of arch aortic disease. 
Methods: Retrospective study of procedures performed from Janu-
ary 2010 to December 2012. The end points were the technical success, 
therapeutic success, morbidity and mortality, neurologic outcomes, the 
rate of endoleaks and reinterventions.
Results: A total of 95 patients treated for thoracic aortic diseases in 
this period, 18 underwent hybrid treatment and entered in this study. 
The average ages were 62.3 years. The male was present in 66.7%. The 
technical and therapeutic success was 94.5% e 83.3%. The periopera-
tive mortality rate of 11.1%. There is any death during one-year fol-
low-up. The reoperation rates were 16.6% due 2 cases of endoleak Ia 
and one case of endoleak II. There is any occlusion of anatomic or extra 
anatomic bypass during follow up. 
Conclusion: In our study, the hybrid treatment of aortic arch disease 
proved to be a feasible alternative of conventional surgery. The therapeu-
tic success rates and re- interventions obtained demonstrate the necessity 
of thorough clinical follow-up of these patients in a long time.
Descriptors: Blood Vessel Prosthesis Implantation. Cerebral Revascular-
ization. Aortic Aneurysm, Thoracic. Aneurysm, Dissecting. Aortic Diseases.
 
Resumo
Introdução: O manejo das doenças da aorta torácica que envolvem a 
aorta ascendente, arco aórtico e aorta torácica descendente constituem um 
desafio técnico e é uma área em constante desenvolvimento e inovação. 
Objetivo: Analisar os resultados iniciais e a médio prazo do trata-
mento híbrido das doenças do arco aórtico. 
528
Rev Bras Cir Cardiovasc | Braz J Cardiovasc Surg
Rev Bras Cir Cardiovasc 2014;29(4):527-36Metzger PB, et al. - Hybrid treatment of aortic arch disease
INTRODUCTION
The management of patients with thoracic aortic diseas-
es involving the ascending aorta, aortic arch and descending 
thoracic aorta are a technical challenge and is an area in con-
stant development and innovation[1,2]. Traditionally, the total 
surgical repair of the aortic arch demand a period of deep 
hypothermic circulatory arrest, which can cause high rates of 
perioperative morbimortality[1-3].
The supra-aortic trunk derivations followed by the en-
dovascular aortic repair is a less invasive alternative for the 
treatment of this serious condition, having been reported 
in several clinical trials, systematic reviews and recent me-
ta-analyzes[3-5].
The total endovascular repair of the aortic arch has been 
a promising method in the last two decades, however, there 
is information divergence in the literature on the safety of the 
short-and-medium-term technique, patient selection criteria, 
in addition, little is known about the material durability and 
the long-term method[5-8].
The data available in the literature of different types of 
treatment are the result of small case series with heteroge-
neous samples and limited follow-up of patients[9]. Therefore, 
the ideal method for the treatment of aortic arch disease is 
still a matter of intense debate.
The objective of this study is to analyze the results in the 
short and medium term of a consecutive series of patients un-
dergoing hybrid treatment of the aortic arch disease having as 
the outcomes studied the technical and therapeutic success, 
perioperative morbimortality and 1 year after the treatment, 
neurological outcomes after 30 days, the leak rate and rein-
tervention during the follow-up period.
Métodos: Estudo retrospectivo de procedimentos realizados no perí-
odo de janeiro de 2010 a dezembro de 2012, em que foram analisados o 
sucesso técnico e terapêutico, a morbimortalidade, os desfechos neuro-
lógicos, a taxa de vazamentos e de reintervenções. 
Resultados: Em um total de 95 pacientes tratados por doenças da 
aorta torácica no período, 18 realizaram o tratamento híbrido e aden-
traram neste estudo. A idade média foi de 62,3 anos. O sexo masculino 
esteve presente em 66,7%. O sucesso técnico e terapêutico foi de 94,5% 
e 83,3%, respectivamente. A mortalidade perioperatória foi de 11,1%. 
Não houve óbito durante o acompanhamento de 1 ano. A taxa de rein-
tervenção foi de 16,6%, devido a 2 casos de endoleak tipo Ia e um caso 
de endoleak tipo 2. Não foi observada oclusão dos enxertos anatômicos 
ou extra-anatômicos durante o período de seguimento. 
Conclusão: O tratamento híbrido das doenças do arco aórtico de-
monstrou ser uma alternativa viável à cirurgia convencional. As taxas 
de sucesso terapêutico e de reintervenções demonstram a necessidade 
do seguimento clínico rigoroso desses pacientes a longo prazo.
Descritores: Implante de Prótese Vascular. Revascularização Cerebral. 
Aneurisma da Aorta Torácica. Aneurisma Dissecante. Doenças da Aorta.
METHODS
Type of study
This is a retrospective, longitudinal and observational 
study carried out in two reference centers for cardiovascular 
diseases, from January 2010 to December 2012, with a total 
of 18 patients undergoing hybrid repair of aortic arch disease.
Inclusion and exclusion criteria
The study included patients of both sexes, with or without 
thoracic symptoms, with indications for aortic correction by:
1. Thoracic aortic aneurysms with a diameter greater than 
60 mm or acute complicated Stanford type B aortic dissec-
tions (AAD), with inadequate proximal anchor zones (length 
<2 cm and/or presence of thrombus or calcified plaques 
greater than 50% of the circumference of the proximal colon)
2. Aortic arch pseudoaneurysm.
3. Penetrating ulcers of the aortic arch and thoracic aorta 
with a diameter of more than 2 cm and a depth of 1 cm with-
out proximal anchor zones.
4. True aneurysms of the aortic arch (TAAA).
5. Chronic type A aortic dissection.
The study excluded patients with: proximal aortic neck fix-
ation with extention greater than 20 mm, diameter of external 
iliac arteries smaller than 7 mm, serum creatinine greater than 
2.0 mg/dl or creatinine clearance less than 30 ml/min.
Patients who underwent endovascular repair of thorac-
ic aortic aneurysm and those who did not undergo the su-
pra-aortic trunk revascularization were excluded from the 
present study.
The evaluation of cardiac and/or anesthetic risk was not 
considered in the inclusion or exclusion.
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Fig. 2 - Anchoring zones of the thoracic aneurysm according to 
Ishimaru and Mitchell classification.
In diseases that affect the Zones 0-2, revascularization 
procedures of the supra-aortic trunks are needed. 
The treatment planning was performed with angiotomogra-
phy in all patients, and the pre-operative arteriogram was an opti-
nal diagnostic method. All scans were reconstructed in OSIRIX® 
MD software 3D mode (three-dimensional) and MPR mode 
(multiplanar reconstruction), and then the diameters, angles and 
extensions of the proximal aortic neck were obtained (Figure 1).
Surgical technique
The extension of the supra-aortic trunks revasculariza-
tion was scheduled after the angiotomography evaluation of 
proximal anchoring zones and stratified using the Ishimaru & 
Mitchell classification[10] (Figure 2):
Zone 0: Revascularization of 3 or 4 supra-aortic vessels 
with median sternotomy (Figure 3A).
Zone 1: Carotid-carotid graft with retropharyngeal tun-
neling or anterior to the trachea associated with the subcla-
vian artery revascularization by transposition or carotid-sub-
clavian graft (Figure 3B).
Zone 2: Subclavian artery revascularization byb transpo-
sition or carotid-subclavian graft (Figure 3C).
Endovascular technique
All procedures were performed in the catheterization 
laboratory of the Endovascular Intervention Center (CIEV) 
of Dante Pazzanese Carfiology Institute and Salvalus Hos-
pital, by the same group of vascular, cardiovascular sur-
geons and interventional radiologists.
Fig. 1 - Angiotomography with multiplanar and three-dimensional reconstruction.
A: Axial section demonstrating the dissection of the left subclavian artery origin. B: Larger diameter of the aorta. C: 
Sagittal section. D: Superior mesenteric artery originating from the true light. E: Involvement of the abdominal aorta. F: 
Dissection at the level of the left iliac artery. G: Three-dimensional reconstruction of the left anterior oblique. H: Three-
dimensional reconstruction of the right anterior oblique.
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The patients were treated under inhalation general anes-
thesia. Antibiotic prophylaxis was performed with 1.5 g of 
cefuroxime at the anaesthetic induction time. The approach 
was preferably carried out through the common femoral ar-
tery by unilateral open surgical dissection. As it was unsuc-
cessful, we decided to approach the external iliac artery using 
a retroperitoneal approach.
Radiographic control was performed with Siemens® Artis 
Flat Panel device or in hybrid room with Siemens® Artis zee-
go Hybrid device. The devices used were: Valiant® (Medtron-
ic Inc, Santa Rosa, Calif), Zenith TX2® (Cook, Bloomington, 
Ind), Tag® (WL Gore & Assoc, Flagstaff, Ariz), Relay® (Bolton 
Medical, Sunrise, Fla). The diameters of the stents ranged 
from 10% to 20% depending on the aortic disease that has to 
be treated. In cases of true aneurysms, we used an oversize of 
20% and in the case of dissection, 10% to 15%.
The drainage of cerebrospinal fluid was carried out in se-
lected cases depending on the extent of coverage of the aorta 
or presence of previous aortic surgeries.
In patients where the prostheses were implanted in Zone 
0, tachycardia induced by temporary pacemaker was used. In 
cases of implantation in zone 1 and 2, permissive hypoten-
sion was used for accurate endoprosthesis deployment.
Intraoperative angiography was performed in all patients. 
The immediate postoperative period was performed in an in-
tensive care unit in all cases.
Postoperative follow-up
Patients were followed up with outpatient evaluation on 
the 15th, 30th, 180th, and 360th days after the correction. Af-
ter the first year, the consultations were held annually. The 
control with angiotomography was performed on the 30th 
and 360th days of the follow-up period. Ultrasound - Doppler 
(USG-D) was performed on the 30th and 180th days and annu-
ally in order to evaluate the patency of the supra-aortic grafts.
Outcomes and definitions
The primary outcome analyzed were defined as follows:
1 - Technical Success: When the derivation of the su-
pra-aortic trunks was carried out in a previously planned 
manner; the objective to release the stent in the affected area 
has been achieved, even in the presence of leaks or other 
events that could adversely influence the evolution of aortic 
disease.
2 - Therapeutic Success: The stent deployment occurred 
without type I and/or III endoleak, or other complications 
that would affect the favorable development of aortic dis-
ease, preserving the patency of the supra-aortic trunk revas-
cularizations.
3 - Perioperative Mortality: Number of deaths registered 
within the first 30 days after the procedure.
4 - Neurological morbidity in the first 30 days: ischemic 
cerebrovascular accident (ICVA) and paraplegia secondary 
to spinal cord ischemia.
5 - Mortality during the one-year-follow-up period.
RESULTS
In the period from January 2010 to December 2012, 95 
endovascular correction of thoracic aortic diseases were per-
formed, in which 18 patients underwent hybrid fix consec-
utively. The demographic characteristics, comorbidities and 
treatment indications are described in Table 1. The mean age 
was 62.3±8.3 years, with prevalence of males. The patients 
were asymptomatic in 13 cases (72.2%), and they were di-
agnosed in routine examinations findings. Hypertension was 
present in all patients. Among the present comorbidities, we 
found a high incidence of chronic obstructive pulmonary dis-
ease (COPD) (44.4%) and ischemic heart disease (27.8%). 
We also observed that 2 patients underwent previous correc-
tion of aortic aneurysm (11.1%) and 1 underwent endovas-
Fig. 3 - Carotid-left subclavian graft with prosthesis anchoring in Zone 2. A=Angiotomography in axial section 
showing massive thoracic aneurysm without proximal landing zone. B=Three-dimensional reconstruction of 
pre-implanted stents. C=Digital subtraction angiotomography with endoprosthesis anchoring in Zone 2 and 
carotid-suclavian patent graft. D=Three-dimensional angiographic reconstruction after stent implantation 
without leaks.
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cular repair of abdominal aortic aneurysm. (Table 1) Most 
of the indications for hybrid treatment were: true aneurysms 
of the aortic arch and descending thoracic aorta with colon 
anchoring <2 cm or unfavorable (Table 1).
Most patients were electively treated (72.2%), with the 
hybrid treatment staged in two phases. Five patients with 
type A dissection or complicated acute B dissection under-
went emergency surgery with surgical and endovascular 
treatment at the same time. Inhalation general anesthesia 
was used in all cases with selective cerebrospinal fluid 
drainage.
The techniques used for the supra-aortic trunk revascu-
larizations are described in Table 2. Eight anatomical grafts 
were performed (total revascularization of the aortic arch) 
and 10 extra-anatomic grafts (left-right carotid-carotid 
grafts and/or grafts or left carotid-subclavian transposi-
tion). All anatomical grafts were made with bifurcated and/
or straight Dacron prosthesis.The extra-anatomic bridges 
were performed using PTFE annealed 6 or 8 with retropha-
ryngeal tunneling in 2 cases and 1 case of tunneling anterior 
to the trachea.
Regarding the left subclavian carotid bridges, 7 trans-
positions of subclavian artery and 3 carotid-subclavian 
grafts. One of the patients have had previous correction 
of the ascending aorta, thus, we performed a graft of the 
ascending aorta-brachiocephalic trunk associated with ca-
rotid-carotid graft, and then, a vascular plug implantation 
in the origin of the brachiocephalic trunk and endovascu-
lar aortic repair with stent implantation in Zone 0. In this 
case, intentional occlusion of the left subclavian artery was 
performed after confirmation of patency and dominance 
of the right vertebral artery (Figure 3). Venous, lymphatic 
or neurological lesions were not observed during the in-
tra-and postoperative period. During the one-year-follow-
up period, there were no occlusions or hemodynamically 
significant stenoses in the anatomical or extra-anatomic 
grafts (Figures 4 and 5).
The revascularizations requiring the segment exchange 
of the ascending aorta were performed with total cardiac ar-
rest and cardiopulmonary bypass, as in cases where only the 
supra-aortic revascularization was used, the proximal anas-
tomosis was performed by partial aortic clamping without 
interruption flow. The cervical anastomoses were marked 
with radiopaque material in order to facilitate the endopros-
thesis implantation. All aortic accesses were performed by 
conventional median sternotomy. Cervical access via supra-
clavicular incision and/or unilateral or bilateral anterior cer-
vical were used depending on the desired type of supra-aortic 
revascularization.
The technical success was achieved in 94.5%, in other 
words, we were able to perform the programmed supra-aor-
tic graft in 17 patients and, insert the stent into the desired 
position.
Characteristics population
Mean age (years)
Male
Symptomatic disease
True TAA
Pseudoaneurysms
AAA
Acute type B dissection
Acute type A dissection
Chronic type A dissection
Diabetes Mellitus
Hypertension
Dyslipidemia
Smoking
Chronic renal failure
Ischaemic heart disease
Chronic Obstructive Pulmonary Disease
Prior aortic surgery
Cerebrovascular accident
Congestive heart failure
n=18
62.3±8.3
12 (66.7%)
5 (27.8%)
6 (33.3%)
1 (5.5%)
4 (22.2%)
2 (11.1%)
3 (16.6%)
2 (11.1%)
6 (33.3%)
18 (100%)
12 (66.7%)
12 (66.7%)
1 ( 5.5%)
5 (27.8%)
8 (44.4%)
3 (16.7%)
0
4 (22.2%)
Value (%)
Table 1. Clinical data (n=18).
TAA= thoracic aortic aneurysm; AAA= aortic arch aneurysm;
Stanford type A and B classification
Ao-Ao=aorto-aortic; BCT=brachiocephalic trunk; LCC=left 
common carotid artery; Sbc=subclavian artery; RCC=Right 
commom carotid artery
Revascularization
description 
2 Ao-Ao bridges + BCT 
revascularization + LCC 
+ Sbc
5 Ao-BCT bridges + Ao-
LCC + Sbc
1 Ao-BCT bridge (single 
carotid aortic trunk) + BCT 
proximal embolization
3 RCC-LCC bridges + Sbc 
transposition
1 Sbc-LCC transposition 
(single carotid trunk)
3 Sbc-LCC transposition
3 Sbc-LCC bridges
15 patients used endopros-
thesis
3 patients used two endo-
prostheses
Number
of events (%) 
13 (72.2%)
8 (44.4%)
4 (22.2%)
6 (33.3%)
21
Technical details
Staged procedures
Zone 0
Zone 1
Zone 2
Numbers of
endoprostheses used
Table 2. Technical details of 18 supra-aortic trunk revascularizations.
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Fig 4 - Carotid-carotid graft associated with transposition of the left subclavian artery and stent-graft 
implantation in Zone 1. A: Angiotomography in sagittal section with thoracic aneurysm without proper 
anchoring zone in Zone 2 due to extreme proximity between the left carotid and the left subclavian arteries. 
B: Angiotomography in axial section showing massive thoracic aneurysm. C: Angiotomography with volume 
reconstruction. D: Supra-aortic trunk revascularizatoins with carotid-carotid graft associated with transposition 
of the left subclavian artery. E: Aortography before stent implantation with patency of anatomical extra grafts. 
F: Aortography after stent implantation demonstrating the aortic stent in Zone 1, no leaks and patency of 
supra-aortic trunks.
Therapeutic success was 83.3%, in other words, the pros-
thesis was inserted in 15 patients without leaks or other com-
plications that would jeopardize the favorable evolution of 
the intervention. The therapeutic failure causes were the type 
I leak in two cases and one death in the intraoperative peri-
od during a correction of Stanford type A dissection, which 
evolved with retrograde dissection and aortic rupture with 
cardiac tamponade.
The in-hospital postoperative complication rate was 
27.7%, as follows: two ischemic neurological injuries 
(11.1%), two cases of pulmonary complications (11.1%) and 
one case of acute renal failure (5, 5%) (Table 3).
The perioperative mortality was 11.1%. The two deaths 
occurred due to retrograde type A dissection: one by rupture 
and acute cardiac tamponade during the endovascular treat-
ment and another by left coronary trunk dissection and acute 
myocardial infarction on the 8th day after surgery (Table 4). 
There were no deaths after the 30-day-follow-up period.
The primary leak rate was 16.6%, with the type I endoleak 
in two cases and type II in one case. No cases of type III leaks 
and stent migration during follow-up were observed. The rein-
tervention rate after one year was 16.7% due to the treatment 
of type I and II leaks in a satisfactory manner (Table 4). The 
annual survival during our follow-up period was 89.9%.
The stent devices used were: in seven cases (38.9%) Ze-
nith TX2® (Cook Medical, Bloomington, INC, USA), in six 
cases (33.3%) Tag® (Gore Medical, Flagstaff, AZ, USA) in 
three cases (16.6%) Valiant® (Medtronic, Minneapolis, MN, 
USA), and in two cases (11.1%) Relay® (Bolton Medical, 
Sunrise, Fla). We used a total of 21 stents.
The average time of endovascular procedure was 65 min 
(ranging from 48 to 151 minutes), the average time of the 
supra-aortic trunk revascularization was 196 minutes and the 
mean hospital stay was 9.7 days, with a 10-day variation. The 
mean follow-up time was 13 months (5-22 months).
DISCUSSION
The improvement of endovascular techniques and the 
association to surgical revascularization of the supra-aortic 
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Outcomes
Intraoperative complications
Peripheral embolization
Femoral lesion
Cardiac tamponade
Intra-hospital complications
Paraplegia
Pulmonary complications
ICVA
Acute renal failure
Acute myocardial infarction
Death
Sample
n=18
0
0
1 (5.5%)
1 (5.5%)
2 (11.1%)
1 (5.5%)
1 (5.5%)
1 (5.5%)
2 (11.1%)
Number of events (%)
Table 3. Intra-and perioperative complications (n = 18).
ICVA=Ischemic cerebrovascular accident
Sample
n=18
3 (16.6%)
2 (11.1%)
0
1 (5.5%)
0
0
3 (16.6%)
Endoleak types
Total
Type IA
Type IB
Type II
Type III
Type IV
Reintervention rate
Number of events (%)
Table 4. Primary leak data (n = 18).
Fig. 5 - Brachiocephalic ascending aorta graft associated with carotid-carotid graft placement of vascular plug 
and aortic endoprosthesis implantation in Zone 0. Intentional occlusion of left subclavian artery.
A=Brachiocephalic ascending aorta surgical graft. B=Preoperative arteriography showing patency of 
brachiocephalic trunk ascending aorta and right-left carotid-carotid artery. C=Stent implantation in Zone 0 and 
subtraction arteriograph via right subclavian artery demonstrating type 2 leak coming from the brachiocephalic 
trunk with left subclavian artery filling. D=Implantation of 22 mm vascular plug in the ostium of the brachiocephalic 
trunk. E=Arteriography control without type 2 leak F=Thoracic aortography without leaks and with disconnection 
of native supra-aortic trunks
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trunks allowed its application in aortic arch diseases, territory 
in which the conventional surgical treatment can bring high 
morbimortality rates[11]. Systematic reviews and recent clini-
cal studies have confirmed the benefits of endovascular meth-
od over conventional surgery in this aortic segment[1-3,7,11-13]. 
A suitable anchoring zone in which there is at least 2 cm of 
healthy aortic extension is required for proper stent implanta-
tion, thereby preventing type I endoleak and maintaining the 
prosthesis durability for a long period[14].
For patients with unfavorable proximal colon, the su-
pra-aortic trunk revascularizations, with the advanced en-
dovascular aortic device for healthy aortic zones, make the 
treatment of this disease feasible, avoiding the conventional 
surgical procedure that requires circulatory arrest and deep 
hypothermia. The mortality of the conventional surgical pro-
cedure on the aortic arch varies 0.9 9.3%  even in centers 
with a large number of surgery[3,15,16]. However, according to 
data from the National Inpatient Sample Database and Medi-
care Provider Analysis and Reviewer, that better reflect the 
global reality, mortality rates range from 15 to 20%[17-20]. De-
spite the invasiveness of the hybrid technique, its degree of 
morbidity can be minimized by using shorter aortic clamping 
or partial clamping techniques when you need to advance the 
prosthesis to Zone 0. In cases where a suitable landing co-
lon can be obtained in Zones 1 and 2, the procedures staged 
without aortic clamping with the use of extra-anatomic grafts 
should be used[2,3].
We obtained a technical success rate of 94.5% and a ther-
apeutic success rate. The technical success rate was influ-
enced by intraoperative death, while the therapeutic success 
rate was influenced by the presence of type IA endoleaks, 
generating a primary leak rate of 16.6%. Both type IA leaks 
were treated with the advancement of a second larger diame-
ter endoprosthesis with the leak fully sealed, whereas the type 
II leak through the subclavian artery was embolized using a 
spring, which generated a reintervention rate of 16.6%. Mou-
lakakis et al.[1] reported a technical success rate of 92.8%, 
with a similar leak rate of 16.6%, which were mostly type I 
endoleaks. The authors explain this data due to the presence 
of retrograde type A dissection in 4.5% of their patients with 
the advancement of the stent to Zone 0[1].
Currently, the late results of the hybrid treatment of the 
aortic arch are not well known, with the most studies report-
ing a follow-up period of 15 to 18 months[6,21]. These data are 
extremely scarce and heterogeneous when the endoleaks are 
specifically evaluated. This rate varies in the literature from 0 
to 15%, and the long-term data leaks are virtually absent[4,8,21]. 
Czerny et al.[4] in a recent study of transcontinental record 
data including 66 patients with complete revascularization of 
the aortic arch and a mean follow-up period of 25 months, 
only one late endoleak type IB and a 5-year survival of 96% 
was observed by the researchers. On the other hand, Vallejo 
et al.[6] in a series of 38 hybrid repair of the aortic arch, with 
a mean follow-up perid of 28 months, found four type I and 
two type II endoleaks[6]. Bavaria et al.[8] in a 30-month-fol-
low-up period, did not observe the presence of type I or III 
leaks. In our study, we observed the presence of late type I, II 
and III leaks during the mean follow-up period of 13 months.
The population of our study showed high risk for conven-
tional surgery due to the high prevalence of chronic obstruc-
tive pulmonary disease (50%) and ischemic heart disease 
(38.9%), and 5 of these patients were treated on an emer-
gency basis due to complicated acute type A a or type B dis-
sections, so our mortality rate in a 30-day-follow-up period 
was 11.1%. One patient died during the intraoperative period 
due to progression of retrograde type A dissection with aortic 
rupture and cardiac tamponade and another patient died on 
the 8th postoperative day due to the progression of type A 
dissection with retrograde left coronary trunk involvement 
and acute myocardial infarction. Brazilian authors reported a 
mortality rate of 16.7% in the perioperative period using the 
same technique[2]. A recent meta-analysis published in 2013, 
with 956 patients analyzed, obtained a perioperative mortal-
ity rate of 11.9%[1]. However, smaller case series have been 
published with mortality rates ranging between 3-6%[3,11].
The neurological injury rates in the literature range from 
4% to 12%[11]. When we separate ICVA of the spinal cord 
from permanent paraplegia, we observed rates of 7.6% and 
3.6% respectively, in the meta-analytic study by Moulakakis 
et al.[1]. In our region, we observed an ICVA rate of 5.5%. 
This occurred during the advancement of the stent to Zone 
0. The occurrence of neurological outcome is directly related 
to the quality of the native aorta, with the unfavorable char-
acteristics the presence of plaques and thrombi in the aortic 
segment[22]. Low ICVA rate found by Shirakawa et al.[11] in 
their clinical study with 40 patients and a follow-up of 15.5 
months, is justified by the author due to careful preoperative 
selection of patients with angiotomography, evaluating the 
endoprosthesis implantation conditions in the ascending aor-
ta. When a healthy aorta was found, the hybrid treatment was 
performed[11].
We had a case of spinal cord ischemia in a patient who 
previously had an open repair of the ascending aorta and prior 
endovascular repair of infrarenal abdominal aortic aneurysm. 
This patient had paraplegia signals on the 3rd postoperative 
day, therefore immediate fluid drainage was performed, how-
ever, this individual remained with permanent paraplegia as a 
sequel. Spinal cord ischemia is directly related to aortic cov-
erage area and the aortic clamping time[1,3,23], thus, spinal cord 
ischemia rates in hybrid procedures are lower when compared 
to the open aortic corrections, since the aortic coverage area 
in hybrid procedures is smaller, as well as the clamping time. 
In this patient, the area of previous aortic management to the 
hybrid procedure favored this complication.
As for the postoperative complications, we highlight the 
low incidence of pulmonary complications (11.1%). Two 
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patients had prolonged weaning and associated pulmonary 
infection being treated in the intensive care unit for a long 
period, but they evolved satisfactorily. The main clinical 
morbidity in the postoperative period of open and hybrid 
treatment of thoracic aortic diseases are pulmonary and car-
diac complications. The rates of these complications were 
19.7% and 6%, respectively, in the meta-analysis published 
in 2013[1]. In our study, we had one death due to acute myo-
cardial infarction caused by retrograde dissection with left 
main coronary artery involvement. Despite the large number 
of COPD patients in our study, the low rate of pulmonary 
complications is explained due to strict stratification and pre-
operative clinical training, as well as intensive care dedicated 
to adequate cardiopulmonary rehabilitation.
The retrograde type A dissection is a complication de-
scribed in the open and endovascular repair of the native as-
cending aorta[1,7,21]. When assessing the clinical studies for the 
presence of this complication, it is observed that the data are 
published in relation to all treated sample, with an absolute rate 
of 3.8% in the most recent meta-analysis published; however, 
when observing only the native ascending aorta at risk, we ob-
tain higher rates of this complication. In the study published 
by Andersen et al.[7], a similar incidence of 3.4% is reported in 
a series of 87 patients with hybrid aortic arch repair. However, 
the authors report that the real rate should be 11.1% (3 of 27 
cases) when they includ only patients with native ascending 
aorta at risk of this complication[3,7]. We had two cases of retro-
grade type A dissection in 16 native ascending aorta (12.5%).
New techniques with the full endovascular management 
of aortic arch aneurysms using branched and fenestrated 
stents are under development. The first clinical study is being 
conducted and, therefore, little is known about the medium 
and long term results of this technique[24]. Endovascular pro-
cedures using the Snorkel and Chaminé techniques, although 
feasible, they expose the patient to type I endoleak and retro-
grade type A dissection[25].
Study limitations
Due to the small number of cases, the heterogeneous 
group of patients and types of procedures performed, as well 
as the short follow-up period, the comparison between the 
techniques and the relationship with their outcomes limit the 
results of our study. Lasty, the accuracy of the results may be 
affected by retrospective analysis of data.
CONCLUSION
In our study, the hybrid treatment of aortic arch disease 
proved to be a technically feasible alternative with short and 
medium term results.
The involvement of the ascending aorta by type A dissec-
tion and the need to implant in Zone 0 had a higher rate of 
acute neurological events and retrograde type A dissection.
The treatment success rates and required reinterventions 
in the various segments of the aortic arch treated demonstrate 
the need for rigorous follow-up of these long-term patients.
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